Press Releases from Trovagene, Inc. (6 total)
Trovagene Cited Among Top Molecular Diagnostic Developers
SAN DIEGO – Trovagene, Inc., a developer of transrenal molecular diagnostics, was placed in lofty company with Abbott Diagnostics and Rosetta Genomics in the increasingly…
Trovagene Called Well-Placed in Global Molecular Diagnostic Industry by NASDAQ
NEW YORK – Fresh from a successful public offering and new listing on the NASDAQ stock exchange, Trovagene CEO Antonius Schuh was given the honor…
Novel Urine Tests for Cancer Under Development to Replace Blood Samples
SAN DIEGO -- Scientists at Trovagene, Inc. (Pink Sheets: TROV.PK), a developer of trans-renal molecular diagnostics, are working to develop novel tests to detect…
TrovaGene Expands Franchise of Proprietary Markers in Hematological Cancers With …
SAN DIEGO -- TrovaGene, Inc. (Pink Sheets: TROV), a developer of trans-renal molecular diagnostics, announced it has obtained an exclusive worldwide license to mutations of…
Antonius Schuh Named CEO of TrovaGene, Inc. and Sets Sights on Novel Diagnostics …
SAN DIEGO -- TrovaGene, Inc. (Pink Sheets: TROV.PK), a developer of trans-renal molecular diagnostics, has announced that Antonius Schuh, Ph.D. has been named Chief…
Aiming to Develop Novel Cervical Cancer Screening Test
SAN DIEGO, CA – TrovaGene, Inc., is preparing to launch clinical studies aimed at developing the first non-invasive, urine-based screening test for the human papilloma…
Go To Page:
